id | C00047901 |
---|---|
Name | Gedunin |
CAS RN | 2753-30-2 |
Standard InChI | InChI=1S/C28H34O7/c1-15(29)33-20-13-18-24(2,3)19(30)8-10-25(18,4)17-7-11-26(5)21(16-9-12-32-14-16)34-23(31)22-28(26,35-22)27(17,20)6/h8-10,12,14,17-18,20-22H,7,11,13H2,1-6H3/t17-,18+,20-,21+,22-,25-,26+,27+,28-/m1/s1 |
Standard InChI (Main Layer) | InChI=1S/C28H34O7/c1-15(29)33-20-13-18-24(2,3)19(30)8-10-25(18,4)17-7-11-26(5)21(16-9-12-32-14-16)34-23(31)22-28(26,35-22)27(17,20)6/h8-10,12,14,17-18,20-22H,7,11,13H2,1-6H3 |
Phytochemical cluster | No. 51 |
---|---|
KCF-S cluster | No. 204 |
By standard InChI | CHEMBL465226 |
---|---|
By standard InChI Main Layer | CHEMBL465226 CHEMBL1335340 CHEMBL2004035 |
By LinkDB |
---|
By CAS RN | C106014 |
---|
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Entandrophragma angolense | 587577 | Meliaceae | rosids | Viridiplantae |
Xylocarpus granatum | 241841 | Meliaceae | rosids | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL1335340 |
CHEMBL1613992
(1)
CHEMBL1613995
(1)
|
7 / 44 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL465226 CHEMBL1335340 |
CHEMBL1613842
(2)
|
4 / 2 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL465226 |
CHEMBL2114784
(1)
|
1 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL465226 |
CHEMBL1614544
(1)
|
11 / 10 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL1335340 |
CHEMBL1794311
(1)
|
2 / 3 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | CHEMBL465226 |
CHEMBL1794584
(1)
|
2 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL465226 |
CHEMBL2114843
(1)
CHEMBL2114780
(1)
|
0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | CHEMBL465226 |
CHEMBL2114788
(1)
|
0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL1335340 |
CHEMBL1794467
(1)
|
0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL465226 |
CHEMBL1738588
(1)
|
0 / 0 |
P08238 | Heat shock protein HSP 90-beta | Other cytosolic protein | CHEMBL465226 |
CHEMBL1664651
(1)
CHEMBL1664652
(1)
CHEMBL1664653 (1) CHEMBL1664660 (1) CHEMBL1664667 (1) |
0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL1335340 |
CHEMBL1614108
(1)
CHEMBL1613886
(1)
|
0 / 1 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | CHEMBL465226 |
CHEMBL1614052
(1)
|
1 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL465226 |
CHEMBL1614421
(1)
|
4 / 3 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL465226 |
CHEMBL1738184
(1)
|
0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL465226 |
CHEMBL2354311
(1)
|
1 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C106014 | 10598 |
AHSA1
AHA1 C14orf3 p38 |
AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast) | gedunin results in increased expression of AHSA1 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 1645 |
AKR1C1
2-ALPHA-HSD 20-ALPHA-HSD C9 DD1 DD1/DD2 DDH DDH1 H-37 HAKRC HBAB MBAB |
aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) | gedunin results in increased expression of AKR1C1 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 1646 |
AKR1C2
AKR1C-pseudo BABP DD DD2 DDH2 HAKRD HBAB MCDR2 SRXY8 |
aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) | gedunin results in increased expression of AKR1C2 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 367 |
AR
AIS DHTR HUMARA HYSP1 KD NR3C4 SBMA SMAX1 TFM |
androgen receptor | gedunin results in decreased expression of AR protein |
decreases expression
|
protein |
17010675
|
C106014 | 84159 |
ARID5B
DESRT MRF-2 MRF2 |
AT rich interactive domain 5B (MRF1-like) | gedunin results in decreased expression of ARID5B mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 467 |
ATF3
|
activating transcription factor 3 | gedunin results in increased expression of ATF3 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 9531 |
BAG3
BAG-3 BIS CAIR-1 MFM6 |
BCL2-associated athanogene 3 | gedunin results in increased expression of BAG3 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 332 |
BIRC5
API4 EPR-1 |
baculoviral IAP repeat containing 5 | gedunin results in decreased expression of BIRC5 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 694 |
BTG1
|
B-cell translocation gene 1, anti-proliferative | gedunin results in decreased expression of BTG1 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 8209 |
C21orf33
ES1 GT335 HES1 KNPH KNPI |
chromosome 21 open reading frame 33 | gedunin results in decreased expression of C21ORF33 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 27101 |
CACYBP
GIG5 RP1-102G20.6 S100A6BP SIP |
calcyclin binding protein | gedunin results in increased expression of CACYBP mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | gedunin results in increased activity of CASP3 protein |
increases activity
|
protein |
21381696
|
C106014 | 841 |
CASP8
ALPS2B CAP4 Casp-8 FLICE MACH MCH5 |
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | gedunin results in increased activity of CASP8 protein |
increases activity
|
protein |
21381696
|
C106014 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | gedunin results in increased activity of CASP9 protein |
increases activity
|
protein |
21381696
|
C106014 | 874 |
CBR3
SDR21C2 hCBR3 |
carbonyl reductase 3 (EC:1.1.1.184) | gedunin results in increased expression of CBR3 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 8317 |
CDC7
CDC7L1 HsCDC7 Hsk1 huCDC7 |
cell division cycle 7 (EC:2.7.11.1) | gedunin results in decreased expression of CDC7 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 1017 |
CDK2
p33(CDK2) |
cyclin-dependent kinase 2 (EC:2.7.11.22) | gedunin results in decreased expression of CDK2 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 26973 |
CHORDC1
CHP1 |
cysteine and histidine-rich domain (CHORD) containing 1 | gedunin results in increased expression of CHORDC1 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 10370 |
CITED2
ASD8 MRG-1 MRG1 P35SRJ VSD2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | gedunin results in decreased expression of CITED2 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | gedunin results in decreased expression of CYP1A1 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 1649 |
DDIT3
CEBPZ CHOP CHOP-10 CHOP10 GADD153 |
DNA-damage-inducible transcript 3 | gedunin results in increased expression of DDIT3 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 54541 |
DDIT4
Dig2 REDD-1 REDD1 |
DNA-damage-inducible transcript 4 | gedunin results in increased expression of DDIT4 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 3301 |
DNAJA1
DJ-2 DjA1 HDJ2 HSDJ HSJ2 HSPF4 NEDD7 hDJ-2 |
DnaJ (Hsp40) homolog, subfamily A, member 1 | gedunin results in increased expression of DNAJA1 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 11080 |
DNAJB4
DNAJW DjB4 HLJ1 |
DnaJ (Hsp40) homolog, subfamily B, member 4 | gedunin results in increased expression of DNAJB4 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 1948 |
EFNB2
EPLG5 HTKL Htk-L LERK5 |
ephrin-B2 | gedunin results in decreased expression of EFNB2 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 1956 |
EGFR
ERBB ERBB1 HER1 PIG61 mENA |
epidermal growth factor receptor (EC:2.7.10.1) | gedunin results in decreased expression of EGFR protein |
decreases expression
|
protein |
17010675
|
C106014 | 11153 |
FICD
HIP13 HYPE UNQ3041 |
FIC domain containing (EC:2.7.7.n1) | gedunin results in increased expression of FICD mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 2322 |
FLT3
CD135 FLK-2 FLK2 STK1 |
fms-related tyrosine kinase 3 (EC:2.7.10.1) | gedunin results in decreased expression of FLT3 protein |
decreases expression
|
protein |
17010675
|
C106014 | 2730 |
GCLM
GLCLR |
glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) | gedunin results in increased expression of GCLM mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 9518 |
GDF15
GDF-15 MIC-1 MIC1 NAG-1 PLAB PTGFB |
growth differentiation factor 15 | gedunin results in increased expression of GDF15 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 54676 |
GTPBP2
|
GTP binding protein 2 | gedunin results in increased expression of GTPBP2 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 29923 |
HILPDA
C7orf68 HIG-2 HIG2 |
hypoxia inducible lipid droplet-associated | gedunin results in decreased expression of HILPDA mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 3157 |
HMGCS1
HMGCS |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) (EC:2.3.3.10) | gedunin results in increased expression of HMGCS1 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 3162 |
HMOX1
HMOX1D HO-1 HSP32 bK286B10 |
heme oxygenase (decycling) 1 (EC:1.14.99.3) | gedunin results in increased expression of HMOX1 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 3320 |
HSP90AA1
EL52 HSP86 HSP89A HSP90A HSP90N HSPC1 HSPCA HSPCAL1 HSPCAL4 HSPN Hsp89 Hsp90 LAP2 |
heat shock protein 90kDa alpha (cytosolic), class A member 1 | gedunin results in decreased activity of HSP90AA1 protein |
decreases activity
|
protein |
17010675
|
C106014 | 3303 |
HSPA1A
HSP70-1 HSP70-1A HSP70I HSP72 HSPA1 |
heat shock 70kDa protein 1A | gedunin results in increased expression of HSPA1A mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 3304 |
HSPA1B
HSP70-1B HSP70-2 |
heat shock 70kDa protein 1B | gedunin results in increased expression of HSPA1B mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 3309 |
HSPA5
BIP GRP78 MIF2 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | gedunin results in increased expression of HSPA5 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 10808 |
HSPH1
HSP105 HSP105A HSP105B NY-CO-25 |
heat shock 105kDa/110kDa protein 1 | gedunin results in increased expression of HSPH1 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 3557 |
IL1RN
DIRA ICIL-1RA IL-1RN IL-1ra IL-1ra3 IL1F3 IL1RA IRAP MVCD4 |
interleukin 1 receptor antagonist | gedunin results in decreased expression of IL1RN mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 3638 |
INSIG1
CL-6 CL6 |
insulin induced gene 1 | gedunin results in increased expression of INSIG1 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 182 |
JAG1
AGS AHD AWS CD339 HJ1 JAGL1 |
jagged 1 | gedunin results in decreased expression of JAG1 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 3781 |
KCNN2
KCa2.2 SK2 SKCA2 SKCa_2 hSK2 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 | gedunin results in decreased expression of KCNN2 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 3949 |
LDLR
FH FHC LDLCQ2 |
low density lipoprotein receptor | gedunin results in increased expression of LDLR mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 23175 |
LPIN1
PAP1 |
lipin 1 (EC:3.1.3.4) | gedunin results in increased expression of LPIN1 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 26046 |
LTN1
C21orf10 C21orf98 RNF160 ZNF294 |
listerin E3 ubiquitin protein ligase 1 | gedunin results in decreased expression of LTN1 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 9935 |
MAFB
KRML MCTO |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B | gedunin results in decreased expression of MAFB mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 4191 |
MDH2
M-MDH MDH MGC:3559 MOR1 |
malate dehydrogenase 2, NAD (mitochondrial) (EC:1.1.1.37) | gedunin results in decreased expression of MDH2 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 4199 |
ME1
HUMNDME MES |
malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) | gedunin results in increased expression of ME1 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 4335 |
MNT
MAD6 MXD6 ROX bHLHd3 |
MAX network transcriptional repressor | gedunin results in increased expression of MNT mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 29074 |
MRPL18
L18mt MRP-L18 |
mitochondrial ribosomal protein L18 | gedunin results in increased expression of MRPL18 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 2956 |
MSH6
GTBP GTMBP HNPCC5 HSAP p160 |
mutS homolog 6 | gedunin results in decreased expression of MSH6 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 6307 |
MSMO1
DESP4 ERG25 SC4MOL |
methylsterol monooxygenase 1 (EC:1.14.13.72) | gedunin results in increased expression of MSMO1 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 23077 |
MYCBP2
PAM |
MYC binding protein 2, E3 ubiquitin protein ligase | gedunin results in decreased expression of MYCBP2 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 55892 |
MYNN
OSZF ZBTB31 ZNF902 |
myoneurin | gedunin results in decreased expression of MYNN mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 4683 |
NBN
AT-V1 AT-V2 ATV NBS NBS1 P95 |
nibrin | gedunin results in decreased expression of NBN mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 4824 |
NKX3-1
BAPX2 NKX3 NKX3.1 NKX3A |
NK3 homeobox 1 | gedunin results in decreased expression of NKX3-1 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 9315 |
NREP
C5orf13 D4S114 P311 PRO1873 PTZ17 SEZ17 |
neuronal regeneration related protein | gedunin results in decreased expression of NREP mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 4986 |
OPRK1
K-OR-1 KOR KOR-1 OPRK |
opioid receptor, kappa 1 | gedunin results in decreased expression of OPRK1 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 51526 |
OSER1
C20orf111 HSPC207 Osr1 Perit1 dJ1183I21.1 |
oxidative stress responsive serine-rich 1 | gedunin results in increased expression of OSER1 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 5152 |
PDE9A
HSPDE9A2 |
phosphodiesterase 9A (EC:3.1.4.35) | gedunin results in decreased expression of PDE9A mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 5293 |
PIK3CD
P110DELTA PI3K p110D |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (EC:2.7.1.153) | gedunin results in decreased expression of PIK3CD mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 5295 |
PIK3R1
AGM7 GRB1 p85 p85-ALPHA |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | gedunin results in decreased expression of PIK3R1 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 10105 |
PPIF
CYP3 CyP-M Cyp-D CypD |
peptidylprolyl isomerase F (EC:5.2.1.8) | gedunin results in decreased expression of PPIF mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 5813 |
PURA
PUR-ALPHA PUR1 PURALPHA |
purine-rich element binding protein A | gedunin results in decreased expression of PURA mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 6241 |
RRM2
R2 RR2 RR2M |
ribonucleotide reductase M2 (EC:1.17.4.1) | gedunin results in decreased expression of RRM2 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 27230 |
SERP1
RAMP4 |
stress-associated endoplasmic reticulum protein 1 | gedunin results in increased expression of SERP1 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 27244 |
SESN1
PA26 SEST1 |
sestrin 1 | gedunin results in decreased expression of SESN1 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 6520 |
SLC3A2
4F2 4F2HC 4T2HC CD98 CD98HC MDU1 NACAE |
solute carrier family 3 (amino acid transporter heavy chain), member 2 | gedunin results in increased expression of SLC3A2 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 23657 |
SLC7A11
CCBR1 xCT |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 | gedunin results in increased expression of SLC7A11 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 79811 |
SLTM
Met |
SAFB-like, transcription modulator | gedunin results in decreased expression of SLTM mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 6659 |
SOX4
EVI16 |
SRY (sex determining region Y)-box 4 | gedunin results in decreased expression of SOX4 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 100380807 | gedunin results in increased expression of STCH mRNA |
increases expression
|
mRNA |
17010675
|
||
C106014 | 10963 |
STIP1
HOP IEF-SSP-3521 P60 STI1 STI1L |
stress-induced-phosphoprotein 1 | gedunin results in increased expression of STIP1 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 51347 |
TAOK3
DPK JIK MAP3K18 |
TAO kinase 3 (EC:2.7.11.1) | gedunin results in decreased expression of TAOK3 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 7113 |
TMPRSS2
PP9284 PRSS10 |
transmembrane protease, serine 2 (EC:3.4.21.-) | gedunin results in decreased expression of TMPRSS2 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 10628 |
TXNIP
EST01027 HHCPA78 THIF VDUP1 |
thioredoxin interacting protein | gedunin results in decreased expression of TXNIP mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 7296 |
TXNRD1
GRIM-12 TR TR1 TRXR1 TXNR |
thioredoxin reductase 1 (EC:1.8.1.9) | gedunin results in increased expression of TXNRD1 mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 7320 |
UBE2B
E2-17kDa HHR6B HR6B RAD6B UBC2 |
ubiquitin-conjugating enzyme E2B (EC:6.3.2.19) | gedunin results in increased expression of UBE2B mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 7358 |
UGDH
GDH UDP-GlcDH UDPGDH UGD |
UDP-glucose 6-dehydrogenase (EC:1.1.1.22) | gedunin results in increased expression of UGDH mRNA |
increases expression
|
mRNA |
17010675
|
C106014 | 79084 |
WDR77
MEP-50 MEP50 Nbla10071 RP11-552M11.3 p44 p44/Mep50 |
WD repeat domain 77 | gedunin results in decreased expression of WDR77 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 23099 |
ZBTB43
ZBTB22B ZNF-X ZNF297B |
zinc finger and BTB domain containing 43 | gedunin results in decreased expression of ZBTB43 mRNA |
decreases expression
|
mRNA |
17010675
|
C106014 | 80149 |
ZC3H12A
MCPIP MCPIP1 RP3-423B22.1 dJ423B22.1 |
zinc finger CCCH-type containing 12A | gedunin results in decreased expression of ZC3H12A mRNA |
decreases expression
|
mRNA |
17010675
|
OMIM | preferred title | UniProt |
---|---|---|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P04637
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG | disease name | UniProt |
---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|